Damien Mcdevitt - Net Worth and Insider Trading
Damien Mcdevitt Net Worth
The estimated net worth of Damien Mcdevitt is at least $4 Million dollars as of 2024-12-28. Damien Mcdevitt is the CEO of Akcea Therapeutics Inc and owns about 242,978 shares of Akcea Therapeutics Inc (AKCA) stock worth over $4 Million. Details can be seen in Damien Mcdevitt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Damien Mcdevitt has not made any transactions after 2020-09-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Damien Mcdevitt
Damien Mcdevitt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Damien Mcdevitt owns 2 companies in total, including Akcea Therapeutics Inc (AKCA) , and Ionis Pharmaceuticals Inc (IONS) .
Click here to see the complete history of Damien Mcdevitt’s form 4 insider trades.
Insider Ownership Summary of Damien Mcdevitt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKCA | Akcea Therapeutics Inc | 2020-10-12 | director & Chief Executive Officer |
| IONS | Ionis Pharmaceuticals Inc | 2018-06-18 | Chief Business Officer |
Damien Mcdevitt Latest Holdings Summary
Damien Mcdevitt currently owns a total of 1 stock. Damien Mcdevitt owns 242,978 shares of Akcea Therapeutics Inc (AKCA) as of September 22, 2020, with a value of $4 Million.
Latest Holdings of Damien Mcdevitt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKCA | Akcea Therapeutics Inc | 2020-09-22 | 242,978 | 18.17 | 4,414,910 |
Holding Weightings of Damien Mcdevitt
Damien Mcdevitt Form 4 Trading Tracker
According to the SEC Form 4 filings, Damien Mcdevitt has made a total of 2 transactions in Akcea Therapeutics Inc (AKCA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Akcea Therapeutics Inc is the sale of 8,709 shares on September 22, 2020, which brought Damien Mcdevitt around $157,807.
Insider Trading History of Damien Mcdevitt
- 1
Damien Mcdevitt Trading Performance
Damien Mcdevitt Ownership Network
Damien Mcdevitt Owned Company Details
What does Akcea Therapeutics Inc do?
Who are the key executives at Akcea Therapeutics Inc?
Damien Mcdevitt is the director & Chief Executive Officer of Akcea Therapeutics Inc. Other key executives at Akcea Therapeutics Inc include Chief Medical Officer William T. Andrews , Chief Financial Officer Michael Dennis Price , and Chief Commercial Officer Kyle Jenne .
Akcea Therapeutics Inc (AKCA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akcea Therapeutics Inc (AKCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akcea Therapeutics Inc (AKCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akcea Therapeutics Inc (AKCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akcea Therapeutics Inc Insider Transactions
Damien Mcdevitt Mailing Address
Above is the net worth, insider trading, and ownership report for Damien Mcdevitt. You might contact Damien Mcdevitt via mailing address: C/o Ionis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad Ca 92010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
